Danaher Corporation $DHR Stock Position Decreased by New York State Teachers Retirement System

New York State Teachers Retirement System cut its stake in shares of Danaher Corporation (NYSE:DHRFree Report) by 1.4% in the 3rd quarter, Holdings Channel reports. The firm owned 497,961 shares of the conglomerate’s stock after selling 7,240 shares during the quarter. New York State Teachers Retirement System’s holdings in Danaher were worth $98,726,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also made changes to their positions in the stock. White Pine Capital LLC grew its stake in Danaher by 1.4% during the 2nd quarter. White Pine Capital LLC now owns 3,494 shares of the conglomerate’s stock worth $690,000 after buying an additional 49 shares during the last quarter. Boyd Watterson Asset Management LLC OH lifted its stake in Danaher by 2.1% in the second quarter. Boyd Watterson Asset Management LLC OH now owns 2,524 shares of the conglomerate’s stock valued at $499,000 after buying an additional 51 shares during the last quarter. Worth Financial Advisory Group LLC boosted its holdings in shares of Danaher by 4.6% during the second quarter. Worth Financial Advisory Group LLC now owns 1,195 shares of the conglomerate’s stock valued at $236,000 after acquiring an additional 53 shares during the period. Howard Capital Management Group LLC grew its position in shares of Danaher by 4.8% during the third quarter. Howard Capital Management Group LLC now owns 1,159 shares of the conglomerate’s stock worth $230,000 after acquiring an additional 53 shares during the last quarter. Finally, Bruce G. Allen Investments LLC increased its holdings in shares of Danaher by 13.1% in the 2nd quarter. Bruce G. Allen Investments LLC now owns 467 shares of the conglomerate’s stock worth $92,000 after acquiring an additional 54 shares during the period. Institutional investors own 79.05% of the company’s stock.

Danaher Price Performance

NYSE:DHR opened at $238.28 on Friday. The company has a quick ratio of 1.10, a current ratio of 1.52 and a debt-to-equity ratio of 0.33. The business’s 50-day moving average price is $225.77 and its 200 day moving average price is $210.61. Danaher Corporation has a 52-week low of $171.00 and a 52-week high of $258.23. The firm has a market cap of $168.31 billion, a P/E ratio of 49.13, a PEG ratio of 4.24 and a beta of 0.89.

Danaher (NYSE:DHRGet Free Report) last issued its quarterly earnings results on Monday, October 20th. The conglomerate reported $1.89 earnings per share for the quarter, beating analysts’ consensus estimates of $1.72 by $0.17. Danaher had a net margin of 14.44% and a return on equity of 10.92%. The company had revenue of $6.05 billion during the quarter, compared to the consensus estimate of $6 billion. During the same period in the prior year, the company earned $1.71 EPS. Danaher’s revenue was up 4.4% on a year-over-year basis. As a group, sell-side analysts predict that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 30th. Stockholders of record on Friday, December 26th will be given a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date is Friday, December 26th. Danaher’s dividend payout ratio is 26.39%.

Analyst Ratings Changes

A number of research firms have issued reports on DHR. Morgan Stanley assumed coverage on shares of Danaher in a research note on Monday, December 1st. They set an “overweight” rating and a $270.00 target price for the company. Weiss Ratings reiterated a “hold (c)” rating on shares of Danaher in a research report on Monday, December 29th. JPMorgan Chase & Co. raised their target price on Danaher from $260.00 to $270.00 and gave the company an “overweight” rating in a research report on Wednesday, October 22nd. Wall Street Zen upgraded Danaher from a “hold” rating to a “buy” rating in a research report on Saturday, November 22nd. Finally, TD Cowen raised their price target on Danaher from $260.00 to $270.00 and gave the company a “buy” rating in a report on Wednesday. Twenty-one equities research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $249.92.

Get Our Latest Analysis on Danaher

Insider Activity

In other news, Director Teri List sold 3,298 shares of the firm’s stock in a transaction on Tuesday, November 18th. The stock was sold at an average price of $226.50, for a total transaction of $746,997.00. Following the completion of the sale, the director directly owned 20,762 shares of the company’s stock, valued at $4,702,593. This trade represents a 13.71% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, SVP Georgeann Couchara sold 5,174 shares of the business’s stock in a transaction on Monday, November 10th. The stock was sold at an average price of $210.42, for a total value of $1,088,713.08. Following the sale, the senior vice president directly owned 2,625 shares in the company, valued at $552,352.50. This trade represents a 66.34% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders sold 30,248 shares of company stock worth $6,609,663. Insiders own 11.10% of the company’s stock.

Danaher Profile

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Further Reading

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.